STRS Ohio’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

STRS Ohio’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-290	Closed	-$67K	–	1959
2015 Q1	$67K	Buy	+290	New	+$70.1K	﹤0.01%	1665

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

STRS Ohio's BLCM Position: Q2 2015 in Review

STRS Ohio sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2015, closing a stake of 290 shares — an estimated $67K sold.

STRS Ohio first reported a position in BLCM in Q1 2015 and held it in 1 quarter. The position peaked at $67K in Q1 2015. 81 funds tracked by Wall St. Rank hold BLCM as of Q2 2015.

STRS Ohio reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
STRS Ohio sold 290 Bellicum Pharmaceuticals, Inc. shares in Q2 2015, an estimated $67K.
STRS Ohio first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
STRS Ohio's Bellicum Pharmaceuticals, Inc. position peaked at $67K in Q1 2015.
81 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2015.

Based on STRS Ohio's 13F filing for Q2 2015, filed 4 Aug 2015.